HEALTHCARE INSIGHTS
HEALTHCARE INSIGHTS
  • Home
  • #Global Trends
  • #Vietnam
  • #M&A
  • #Regulations
  • #Knowledge
    • #Corporate Wellness
    • #Human Resources
    • #Capability Development
    • #Personal Health
  • #Events
    HEALTHCARE INSIGHTS
    HEALTHCARE INSIGHTS

    Tag: #M&A

    FTC mandates Aurobindo to divest 4 generic drugs to finalize $250 million Lannett acquisition

    19/06/2026 Published by Pharma Biz

    The U.S. Federal Trade Commission (FTC) has issued a proposed consent order requiring Indian drugmaker Aurobindo Pharma to divest four... Read more

    Category: Uncategorized
    Tags: #M&A

    Bayer completes acquisition of Perfuse Therapeutics in a definitive $2.45 billion ophthalmology expansion

    18/06/2026 Published by Pharma Biz

    Global life science giant Bayer has officially finalized its corporate acquisition of biopharmaceutical enterprise Perfuse Therapeutics, Inc. Following the completion... Read more

    Category: Uncategorized
    Tags: #M&A

    Biogen targets immunology expansion with $1 billion buyout of RayThera

    18/06/2026 Published by Pharma Biz

    U.S.-listed biopharmaceutical enterprise Biogen Inc. has struck a definitive agreement to acquire privately-held biotechnology firm RayThera in a transaction valued... Read more

    Category: Uncategorized
    Tags: #M&A

    Healthcare PE firm Altaris to acquire AI drug development outfit Simulations Plus for $375 million

    17/06/2026 Published by Pharma Biz

    Specialized healthcare private equity firm Altaris has entered into a definitive agreement to acquire Simulations Plus, a global leader in... Read more

    Category: Uncategorized
    Tags: #M&A

    Eli Lilly accelerates M&A streak with acquisition of non-opioid pain drug developer 4E Therapeutics

    17/06/2026 Published by Pharma Biz

    U.S. pharmaceutical titan Eli Lilly and Company has announced a definitive agreement to acquire 4E Therapeutics, a biotechnology startup specializing... Read more

    Category: Uncategorized
    Tags: #M&A

    Gedeon Richter and Hetero Labs secure global alliance to develop and market generic Ozempic®

    12/06/2026 Published by Pharma Biz

    Gedeon Richter Plc. (Hungary) and Hetero Labs Ltd. (India) have officially announced the execution of a definitive global collaboration agreement... Read more

    Category: Uncategorized
    Tags: #M&A

    Chiesi Group finalizes $1.9 billion acquisition of KalVista Pharmaceuticals to expand rare disease footprint

    12/06/2026 Published by Pharma Biz

    Chiesi Group, an international research-focused biopharmaceutical corporation and certified B Corp, has officially finalized its corporate acquisition of KalVista Pharmaceuticals... Read more

    Category: Uncategorized
    Tags: #M&A

    AlzeCure enters potential $1 billion global out-licensing pact with Eli Lilly for Alzheimer’s drug

    10/06/2026 Published by Pharma Biz

    Swedish biotech AlzeCure Pharma has announced that it has entered into a definitive collaboration and global out-licensing agreement with Eli... Read more

    Category: Uncategorized
    Tags: #M&A

    GSK secures $10.6 billion takeover of Nuvalent to reinforce oncology pipeline with multi-blockbuster lung cancer assets

    09/06/2026 Published by Pharma Biz

    British drugmaker GSK has entered into a definitive agreement to acquire US-listed lung cancer biotechnology firm Nuvalent for an aggregate... Read more

    Category: Uncategorized
    Tags: #M&A

    Posts pagination

    Previous page Page 1 … Page 4 Page 5 Page 6 … Page 16 Next page

    Facebook

    Map

    Workday: Monday to Friday
    Working hours: 8am to 5pm
    Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

    Please enable JavaScript in your browser to complete this form.
    Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates
    Loading

    Online Members

    Recent Comments

    • GauTruc on New Biotech Startup Secures $125 Million to Advance Pain Medication
    HEALTHCARE INSIGHTS
    All rights reserved